Cancer survival appears to double with common vaccine, researchers say A new study finds that combining the COVID vaccine with immunotherapy may nearly double cancer survival rates — patients lived an average of 37.3 months compared to 20.6 months without the vaccine. Original Source: https://www.foxnews.com/health/cancer-survival-appears-double-common-vaccine-researchers-say
